Is It Time To Sell Or Buy Associated British Foods plc, Whitbread plc & ASOS Plc?

Associated British Foods plc (LON:ABF), Whitbread plc (LON:WTB) and ASOS Plc (LON:ASC) are under the spotlight.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The valuation of Associated British Foods (LSE: ABF) has been boosted by Goldman Sachs on Friday, so the obvious question now is whether this would be a great time to take profit after its prolonged weakness. Elsewhere, you may also be tempted to cash in on Whitbread (LSE:WTB) and ASOS (LSE: ASC)…

Here are a few things you should consider before pulling the trigger, however. 

Associated British Foods

Associated British Foods is up 2.4% at the time of writing as Goldman Sachs upped ABF’s target price to 3,120p. ABF currently trades at about 3,000p a share (the average price target from brokers stands at 3,075p), which implies 2015 multiples of 36x for earnings and 16x for adjusted operating cash flow, respectively, falling to 28x and 14.5x in 2016.

Should you invest £1,000 in AstraZeneca right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if AstraZeneca made the list?

See the 6 stocks

On the face of it, ABF is not particularly cheap, but it could belong to a diversified portfolio — this is partly a bet on the possible divestment of its sugar assets. Operating margins are expected to rise until the end of 2017 on the back of rising revenues, which should grow by about 20% over the period, greatly outperforming ABF’s trailing performance. What a forward yield ranging between 1.2% and 1.4% means is that ABF remains a fully fledged play on organic retail growth. 

Whitbread

Whitbread has been trading around its current level of 5,185p a share since mid-February, but is up almost 10% in 2015. It’s less expensive than ABF, with net earnings multiples in the region of 20x for the next couple of years — its cash flow multiples point to a 20% discount versus ABF. 

Its new chief executive, Alison Brittain — who is set to start in early 2016 — has been recently defined by The Guardian as “one of the most powerful women in the City.” 

Given her background in retail banking, she was not an obvious choice, the newspaper noted — yet maybe she is a more obvious choice that many had thought, I’d argue.

It doesn’t look like Whitbread needs a lot of work to be done, to be honest — at least operationally. However, once led by a banker — albeit “just a retail banker,” one banking source pointed out — Whitbread could entertain extraordinary corporate activity such as spin-offs, which have long been rumoured and could help it released shareholder value.

Its balance sheet is strong, but its core margins are not expected to rise as fast as those of ABF. 

ASOS

ASOS is not an easy company to value, but as you might know, it could be a calculated bet in the mid-30s.

As you might also know, though, is that as ASOS continues to grow, falling operating margins may disappoint investors in future, which could sink the stock in a flash, just as it happened in the recent past. 

Trading multiples are almost prohibitive: based on net earnings for 2016 and 2017, ASOS trades at 85x and 70x, respectively. 

That’s not unusual for high-growth businesses, but to justify such a lofty valuation you must believe that revenues will almost double to £1.7bn in 2017, allowing ASOS to report net earnings of about £70m, assuming a steady net income margin at 4.1% over the period.

If that’s the case, ASOS may even start to pay a dividend by 2017.

Should you invest £1,000 in AstraZeneca right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.

And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if AstraZeneca made the list?

See the 6 stocks

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alessandro Pasetti has no position in any shares mentioned. The Motley Fool UK owns shares of ASOS. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Calendar showing the date of 5th April on desk in a house
Investing Articles

Here’s how a £20k ISA could produce £1,580 of passive income in the next year

A Stocks and Shares ISA stuffed with dividend shares can be a lucrative source of passive income. Christopher Ruane explains…

Read more »

Investing Articles

Prediction: 12 months from now, £5,000 invested in Tesla stock could be worth…

Tesla stock has endured a miserable year so far, falling by 29%. Muhammad Cheema takes a look at how it…

Read more »

Investing Articles

See what £10,000 invested in Tesla shares at their mid-December peak is worth today 

As the world absorbs the full scale of Donald Trump's tariffs, Tesla shares are reeling. Investors who bought the stock…

Read more »

Hand flipping wooden cubes for change wording" Panic " to " Calm".
Dividend Shares

2 ‘safe’ LSE dividend stocks to consider as global markets sell off

As global markets experience high levels of volatility due to economic uncertainty, investors are piling into these ‘safe-haven’ dividend stocks.

Read more »

Investing Articles

US stock market rout: an unmissable opportunity for investors?

His tech-heavy portfolio has been smashed by Trump’s tariffs. However, Dr James Fox believes there could be some opportunities in…

Read more »

Investing Articles

After a 13% ‘Trump tariff’ fall, is the Barclays share price too cheap to miss?

Does the Barclays share price fall mean we should all panic and run screaming from the stock market? Nah, of…

Read more »

Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper
Investing Articles

2 investment trusts to consider for a Stocks and Shares ISA

These two investment trusts have a different focus -- but our writer sees both as worth considering, one more for…

Read more »

Investing Articles

Deutsche Bank reiterates Buy rating on 9.6% yielding FTSE 250 stock that was “most shorted in UK”

Our writer investigates why a major broker remains optimistic about a FTSE 250 stock that was once the most shorted…

Read more »